{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:44:23Z","timestamp":1773672263165,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s41030-025-00340-z","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:20:25Z","timestamp":1767885625000},"page":"317-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modeling the Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Singapore: Epidemiological Data Update"],"prefix":"10.1007","volume":"12","author":[{"given":"Karan","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe H.","family":"Kyaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iustina","family":"Chirila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Fernando","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josie","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Yarnoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"340_CR1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2023. [updated 2023]. https:\/\/covid19.who.int\/table. Accessed 4 May 2023."},{"key":"340_CR2","unstructured":"Ministry of Health Singapore. COVID-19 Weekly Stats. 2023 [updated 2023 May, 2024]. https:\/\/data.gov.sg\/collections\/522\/view. Accessed Aug 2024."},{"issue":"1","key":"340_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/ijerph18010252","volume":"18","author":"JB Tan","year":"2020","unstructured":"Tan JB, Cook MJ, Logan P, Rozanova L, Wilder-Smith A. Singapore\u2019s pandemic preparedness: an overview of the first wave of COVID-19. Int J Environ Res Public Health. 2020;18(1):252.","journal-title":"Int J Environ Res Public Health"},{"key":"340_CR4","unstructured":"Ministry of Health Malaysia. Consumer Price Index Report: Aug 2024. 2024 [updated 2024 August 2024]. https:\/\/open.dosm.gov.my\/publications\/cpi_2024-08. Accessed 06 Feb 2025."},{"key":"340_CR5","unstructured":"Ministry of Health Singapore. Status of COVID-19 vaccination among Singaporeans and reasons for not taking additional booster shots.; 2024 [updated 2024 2 July 2024. https:\/\/www.moh.gov.sg\/newsroom\/status-of-covid-19-vaccination-among-singaporeans-and-reasons-for-not-taking-additional-booster-shots. Accessed Feb 2025."},{"key":"340_CR6","volume":"41","author":"RY Tan","year":"2023","unstructured":"Tan RY, Wong B, Lim R, Lee CL, Tan J, Tan KB, et al. Factors associated with delayed diagnosis of symptomatic adult COVID-19 cases presenting to primary care: a population-wide study during transition from Delta to Omicron BA.1 in Singapore. Lancet Reg Health. 2023;41:100919.","journal-title":"Lancet Reg Health"},{"key":"340_CR7","volume":"35","author":"JWK Yau","year":"2023","unstructured":"Yau JWK, Lee MYK, Lim EQY, Tan JYJ, Tan K, Chua RSB. Genesis, evolution and effectiveness of Singapore\u2019s national sorting logic and home recovery policies in handling the COVID-19 Delta and Omicron waves. Lancet Reg Health West Pac. 2023;35:100719.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"340_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41467-023-36566-1","volume":"14","author":"R Grewal","year":"2023","unstructured":"Grewal R, Nguyen L, Buchan SA, Wilson SE, Nasreen S, Austin PC, et al. Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes. Nat Commun. 2023;14(1):1273.","journal-title":"Nat Commun"},{"issue":"14","key":"340_CR9","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMc2210093","volume":"387","author":"S Collie","year":"2022","unstructured":"Collie S, Nayager J, Bamford L, Bekker L-G, Zylstra M, Gray G. Effectiveness and durability of the BNT162b2 vaccine against omicron sublineages in South Africa. N Engl J Med. 2022;387(14):1332\u20133.","journal-title":"N Engl J Med"},{"key":"340_CR10","doi-asserted-by":"crossref","unstructured":"Kirsebom F, Andrews N, Stowe J, Ramsay M, Lopez Bernal J. Effectiveness of the COVID-19 vaccines against severe disease with Omicron sub-lineages BA. 4 and BA. 5 in England. medRxiv. 2022:2022.08.31.22279444.","DOI":"10.1101\/2022.08.31.22279444"},{"key":"340_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00373-0","author":"CY Tan","year":"2023","unstructured":"Tan CY, Chiew CJ, Pang D, Lee VJ, Ong B, Wang L-F, et al. Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study. Lancet Infect Dis. 2023. https:\/\/doi.org\/10.1016\/S1473-3099(23)00373-0.","journal-title":"Lancet Infect Dis"},{"issue":"45","key":"340_CR12","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.15585\/mmwr.mm7145a2","volume":"71","author":"HG Rosenblum","year":"2022","unstructured":"Rosenblum HG, Wallace M, Godfrey M, Roper LE, Hall E, Fleming-Dutra KE, et al. Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines\u2014United States, October 2022. MMWR Morb Mortal Wkly Rep. 2022;71(45):1436\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"340_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/14760584.2023.2290931","volume":"23","author":"K Thakkar","year":"2024","unstructured":"Thakkar K, Spinardi J, Kyaw MH, Yang J, Mendoza CF, Ozbilgili E, et al. Modelling the potential public health impact of different COVID-19 vaccination strategies with an adapted vaccine in Singapore. Expert Rev Vaccines. 2024;23(1):16\u201326.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"340_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/13696998.2022.2071427","volume":"25","author":"M Di Fusco","year":"2022","unstructured":"Di Fusco M, Marczell K, Deger KA, Moran MM, Wiemken TL, Cane A, et al. Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States. J Med Econ. 2022;25(1):605\u201317.","journal-title":"J Med Econ"},{"key":"340_CR15","unstructured":"Singapore Department of Statistics. Singapore Residents By Single Year Of Age And Sex, At End June, Annual. 2023 [updated 2023 September 29, 2023; cited]. https:\/\/tablebuilder.singstat.gov.sg\/table\/TS\/M810731."},{"issue":"8","key":"340_CR16","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1016\/S2214-109X(20)30264-3","volume":"8","author":"A Clark","year":"2020","unstructured":"Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8(8):e1003\u201317.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"340_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70060","volume":"18","author":"HY Tan","year":"2024","unstructured":"Tan HY, Khamis NH, Goh A, Mah TKL, Yeo B, Ngan JY, et al. Singapore\u2019s COVID-19 Genomic Surveillance Programme: Strategies and Insights From a Pandemic Year. Influenza Other Respir Viruses. 2024;18(12):e70060.","journal-title":"Influenza Other Respir Viruses"},{"issue":"12","key":"340_CR18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S1473-3099(22)00692-2","volume":"22","author":"SY Tartof","year":"2022","unstructured":"Tartof SY, Slezak JM, Puzniak L, Hong V, Frankland TB, Ackerson BK, et al. BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA. 4 and BA. 5. Lancet Infect Dis. 2022;22(12):1663\u20135.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"340_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-2600(22)00101-1","volume":"10","author":"SY Tartof","year":"2022","unstructured":"Tartof SY, Slezak JM, Puzniak L, Hong V, Xie F, Ackerson BK, et al. Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case\u2013control study. Lancet Respir Med. 2022;10(7):689\u201399.","journal-title":"Lancet Respir Med"},{"key":"340_CR20","doi-asserted-by":"crossref","unstructured":"Arbel R, Peretz A, Sergienko R, Friger M, Beckenstein T, Yaron S, et al. Effectiveness of the bivalent mRNA vaccine in preventing severe COVID-19 outcomes: an observational cohort study. Available at SSRN 4314067. 2023.","DOI":"10.2139\/ssrn.4314067"},{"key":"340_CR21","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7205e1","author":"R Link-Gelles","year":"2023","unstructured":"Link-Gelles R. Early estimates of bivalent mRNA booster dose vaccine effectiveness in preventing symptomatic SARS-CoV-2 infection attributable to Omicron BA. 5\u2013and XBB\/XBB. 1.5\u2013related sublineages among immunocompetent adults\u2014increasing community access to testing program, United States, December 2022\u2013January 2023. MMWR Morb Mortal Wkly Rep. 2023. https:\/\/doi.org\/10.15585\/mmwr.mm7205e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"42","key":"340_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.15585\/mmwr.mm7142a3","volume":"71","author":"D Surie","year":"2022","unstructured":"Surie D, Bonnell L, Adams K, Gaglani M, Ginde AA, Douin DJ, et al. Effectiveness of monovalent mRNA vaccines against COVID-19\u2013associated hospitalization among immunocompetent adults during BA. 1\/BA. 2 and BA. 4\/BA. 5 predominant periods of SARS-CoV-2 omicron variant in the United States\u2014IVY network, 18 states, December 26, 2021\u2013August 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(42):1327\u201334.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"340_CR23","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm715152e2","author":"D Surie","year":"2022","unstructured":"Surie D. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19\u2013associated hospitalization among immunocompetent adults aged\u2265 65 years\u2014IVY network, 18 states, September 8\u2013November 30, 2022. MMWR Morb Mortal Wkly Rep. 2022. https:\/\/doi.org\/10.15585\/mmwr.mm715152e2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"340_CR24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.47102\/annals-acadmedsg.V52N10p522","volume":"52","author":"J Li","year":"2023","unstructured":"Li J, Nadua K, Chong CY, Yung CF. Long COVID prevalence, risk factors and impact of vaccination in the paediatric population: a survey study in Singapore. Ann Acad Med Singap. 2023;52(10):522\u201332.","journal-title":"Ann Acad Med Singap"},{"key":"340_CR25","unstructured":"Singapore Department of Statistics. CPI Highlights. 2025 [updated 2025]. https:\/\/www.singstat.gov.sg\/whats-new\/latest-news\/cpi-highlights. Accessed 05 Feb 2025."},{"key":"340_CR26","unstructured":"UNESCO Institute of Statistics. Singapore. https:\/\/uis.unesco.org\/en\/country\/sg. Accessed 21 Mar 2025."},{"key":"340_CR27","volume":"26","author":"K Trerayapiwat","year":"2022","unstructured":"Trerayapiwat K, Jinatongthai P, Vathesatogkit P, Sritara P, Paengsai N, Dilokthornsakul P, et al. Using real-world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand. The Lancet Reg Health West Pac. 2022;26:100503.","journal-title":"The Lancet Reg Health West Pac"},{"key":"340_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s41669-020-00250-7","volume":"5","author":"D Sharma","year":"2021","unstructured":"Sharma D, Aggarwal AK, Downey LE, Prinja S. National healthcare economic evaluation guidelines: a cross-country comparison. Pharmacoecon Open. 2021;5:349\u201364.","journal-title":"Pharmacoecon Open"},{"issue":"2","key":"340_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/biology11020190","volume":"11","author":"Z Xu","year":"2022","unstructured":"Xu Z, Zhang H, Huang Z. A continuous Markov-chain model for the simulation of COVID-19 epidemic dynamics. Biology. 2022;11(2):190.","journal-title":"Biology"},{"issue":"6","key":"340_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/rsp3.12372","volume":"12","author":"Z Dehghan Shabani","year":"2020","unstructured":"Dehghan Shabani Z, Shahnazi R. Spatial distribution dynamics and prediction of COVID\u201019 in Asian countries: spatial Markov chain approach. Reg Sci Policy Pract. 2020;12(6):1005\u201325.","journal-title":"Reg Sci Policy Pract"},{"key":"340_CR31","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.cmi.2021.07.002","volume":"Oct;27(10)","author":"A Lochen","year":"2021","unstructured":"Lochen A, Anderson RM. Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations. Clin Microbiol Infect. 2021;Oct;27(10):1546\u201357.","journal-title":"Clin Microbiol Infect"},{"key":"340_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.chaos.2020.110057","volume":"139","author":"I Cooper","year":"2020","unstructured":"Cooper I, Mondal A, Antonopoulos CG. A SIR model assumption for the spread of COVID-19 in different communities. Chaos Solitons Fractals. 2020;139:110057.","journal-title":"Chaos Solitons Fractals"},{"key":"340_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.apm.2020.10.019","volume":"90","author":"JE Amaro","year":"2021","unstructured":"Amaro JE, Dudouet J, Orce JN. Global analysis of the COVID-19 pandemic using simple epidemiological models. Appl Math Model. 2021;90:995\u20131008.","journal-title":"Appl Math Model"},{"key":"340_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.arcontrol.2020.10.005","volume":"50","author":"GC Calafiore","year":"2020","unstructured":"Calafiore GC, Novara C, Possieri C. A time-varying SIRD model for the COVID-19 contagion in Italy. Annu Rev Control. 2020;50:361\u201372.","journal-title":"Annu Rev Control"},{"key":"340_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.chaos.2020.109846","volume":"135","author":"F Nda\u00efrou","year":"2020","unstructured":"Nda\u00efrou F, Area I, Nieto JJ, Torres DF. Mathematical modeling of COVID-19 transmission dynamics with a case study of Wuhan. Chaos Solitons Fractals. 2020;135:109846.","journal-title":"Chaos Solitons Fractals"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-025-00340-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:31:12Z","timestamp":1773667872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-025-00340-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["340"],"URL":"https:\/\/doi.org\/10.1007\/s41030-025-00340-z","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Karan Thakkar\n                      ,\n                      Moe H. Kyaw\n                      ,\n                      Iustina Chirila\n                      ,\n                      and Carlos Fernando Mendoza are employees of Pfizer and may hold stock or stock options of Pfizer. Josie Dodd and Ben Yarnoff are employees of PPD Evidera Health Economics & Market Access, Thermo Fisher Scientific, which received financial support from Pfizer in connection with the study and the development of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}